Kestra Advisory Services LLC Sells 740 Shares of HCA Healthcare, Inc. $HCA

Key Points

• Kestra Advisory Services LLC reduced its stake in HCA Healthcare by 11.3% by selling 740 shares, leaving them with a total of 5,829 shares valued at approximately $2,014,000.
• HCA Healthcare reported earnings of $6.84 per share, exceeding expectations, and its revenue grew by 6.4% year-over-year to $18.61 billion.
• The company declared a quarterly dividend of $0.72 per share, with a dividend yield of 0.7%, set to be paid on September 30th.

Kestra Advisory Services LLC trimmed its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 11.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,829 shares of the company's stock after selling 740 shares during the period. Kestra Advisory Services LLC's holdings in HCA Healthcare were worth $2,014,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Avantax Advisory Services Inc. raised its position in shares of HCA Healthcare by 0.4% in the first quarter. Avantax Advisory Services Inc. now owns 8,077 shares of the company's stock valued at $2,791,000 after buying an additional 32 shares in the last quarter. Horizon Investments LLC grew its position in HCA Healthcare by 1.1% in the first quarter. Horizon Investments LLC now owns 3,175 shares of the company's stock valued at $1,097,000 after acquiring an additional 33 shares during the last quarter. Catalyst Financial Partners LLC increased its position in HCA Healthcare by 4.3% during the 1st quarter. Catalyst Financial Partners LLC now owns 872 shares of the company's stock worth $301,000 after purchasing an additional 36 shares in the last quarter. RWA Wealth Partners LLC raised its stake in shares of HCA Healthcare by 2.0% during the first quarter. RWA Wealth Partners LLC now owns 1,904 shares of the company's stock valued at $658,000 after acquiring an additional 37 shares during the last quarter. Finally, Moors & Cabot Inc. boosted its stake in shares of HCA Healthcare by 4.8% in the 1st quarter. Moors & Cabot Inc. now owns 858 shares of the company's stock valued at $297,000 after purchasing an additional 39 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

HCA has been the subject of a number of recent analyst reports. Royal Bank Of Canada decreased their price target on HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating for the company in a report on Monday, July 28th. Bank of America lowered HCA Healthcare from a "buy" rating to a "neutral" rating and set a $394.00 price objective for the company. in a research report on Wednesday, July 16th. Wolfe Research downgraded HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research note on Monday, July 28th. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $444.00 price target on shares of HCA Healthcare in a research report on Tuesday, August 26th. Finally, Robert W. Baird raised their price target on shares of HCA Healthcare from $380.00 to $423.00 and gave the company a "neutral" rating in a research report on Thursday, August 14th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and nine have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, HCA Healthcare has a consensus rating of "Moderate Buy" and an average price target of $401.83.

HCA Healthcare Stock Down 0.8%

NYSE:HCA traded down $3.17 on Monday, hitting $404.11. The stock had a trading volume of 996,401 shares, compared to its average volume of 1,110,551. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98. The firm's fifty day simple moving average is $377.43 and its two-hundred day simple moving average is $357.80. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The stock has a market cap of $94.56 billion, a P/E ratio of 16.99, a price-to-earnings-growth ratio of 1.27 and a beta of 1.41.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $6.20 by $0.64. The business had revenue of $18.61 billion for the quarter, compared to analysts' expectations of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The firm's quarterly revenue was up 6.4% compared to the same quarter last year. During the same period in the previous year, the business posted $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be given a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Tuesday, September 16th. HCA Healthcare's payout ratio is 12.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.